💥Join UPSC 2027,2028 Mentorship (August Batch) + XFactor Notes & Microthemes PDF
Talk to Mentor

Civilsdaily

Login

Subject: Sectoral Regulatory Bodies

  • Due diligence: curbs on surrogate advertising must avoid regulatory overreach

    Why in the News

    The Maharashtra Food and Drug Administration (FDA) Commissioner has begun summoning celebrity endorsers of a pan masala brand, treating the endorsement as a surrogate promotion of tobacco. The action moves enforcement from the manufacturer to the person who supplies the brand recall, and it tests whether the state can discharge the burden of proof that the courts have already placed on it.

    What is surrogate advertising?

    1. Definition: Surrogate advertising is the promotion of a banned product through a legally saleable substitute that carries the same brand name, packaging and visual identity.
    2. How it operates: A tobacco or liquor manufacturer registers an extension product such as elaichi, soda or music CDs, then advertises that extension so the parent brand stays visible where direct advertising is prohibited.
    3. The legal test: An advertisement becomes surrogate when the substitute product has no market identity independent of its association with the prohibited product.
    4. The case at hand: The FDA holds that the pan masala brand endorsed by three leading film actors has no identity independent of tobacco, so endorsing it amounts to endorsing tobacco.

    What is endorser liability?

    1. Meaning: Endorser liability is the statutory responsibility placed on a celebrity or influencer for a false or misleading claim made in an advertisement they lend their name to.
    2. Source of the duty: The Consumer Protection Act, 2019 created this liability along with monetary penalties, which removes ignorance of the manufacturer’s intent as a defence.

    Why has enforcement shifted from the manufacturer to the endorser?

    1. The asymmetry named: The person carrying the persuasive power bears almost none of the health or economic cost of the product being consumed.
    2. Where the cost lands: The consumer absorbs that cost, and an underfunded public health system absorbs the treatment burden that follows.
    3. Why the manufacturer route stalls: Brand extension is legal on its face, so acting only against the manufacturer leaves the advertisement itself untouched.
    4. Why the endorser route bites: Requiring endorsers to explain their decision making applies the endorser liability principle at the enforcement stage rather than only after a complaint.
    5. The wider field: The same asymmetry runs through advertisements making unsubstantiated health claims such as “boosts immunity”, and through educational and financial products.

    What must the state prove before it can call an advertisement surrogate?

    1. The governing ruling: The Delhi High Court in DGHS vs Som Pan Product Pvt. Ltd. (2024) held that the state carries the responsibility of proving a case of surrogate advertising.
    2. Brand registration is not proof: The mere registration of an extension brand does not by itself establish that the advertisement is surrogate.
    3. Legality is not a shield either: The existence of a technically legal product does not automatically permit the particular advertisement built around it.
    4. What follows for the FDA: Suspicion must be converted into inquiries under the Cigarettes and Other Tobacco Products Act (COTPA), 2003 and its Rules and under the Food Safety and Standards Act, 2006 that survive judicial scrutiny.

    Why does the existing regulatory regime struggle with such advertisements?

    1. Fragmentation: Regulation is scattered across a series of Acts and Rules with no single authority owning the surrogate advertising question end to end.
    2. Forum shopping: Advertisers use the multiplicity of legal and administrative instruments to draw the judiciary into the dispute and stall enforcement.
    3. Definitional gap: No statute defines the threshold at which an extension product’s independent market identity becomes real rather than nominal.
    4. Health stakes: India carries the world’s largest burden of oral cancer, which is what makes treatment of these advertisements as unfair trade practices a consumer health question rather than a marketing dispute.

    Does tougher enforcement strengthen the rule or invite regulatory overreach?

    1. The case for acting: Penalties or prohibitions in this case would materially narrow the space that surrogate advertising currently exploits.
    2. The case for restraint: An action that fails the evidentiary standard set in 2024 becomes a precedent that advertisers cite in every later proceeding.
    3. The self defeating outcome: Enforcement seen as arbitrary strengthens the very practice it was meant to end, by converting a public health question into a dispute about administrative excess.
    4. The distinction that matters: Targeting the marketing chain is legitimate, targeting individuals without completing the statutory inquiry is not.

    Challenges to regulating surrogate advertising

    1. Proving the negative: The state must establish that a lawfully sold product has no independent market, which requires sales and distribution evidence that regulators rarely collect. e.g. brand extensions in elaichi and mouth freshener categories report genuine retail sales, which manufacturers cite as proof of independent identity.
    2. Split jurisdiction: Tobacco control sits with the health administration, food safety with the FDA and unfair trade practices with consumer authorities, so no single body carries the case through. e.g. the present action begins with a state FDA whose primary statute is the Food Safety and Standards Act, 2006, not COTPA.
    3. Digital advertising escapes the frame: Influencer posts and platform advertisements are transient and geo targeted, so they leave little evidence for a later inquiry. e.g. short video endorsements of betting and fantasy gaming platforms circulate widely without the disclosure labels print and television carry.
    4. Weak deterrence in practice: Penalties are small relative to advertising budgets and are contested for years. e.g. tobacco control prosecutions under COTPA are typically compounded at low fines rather than pursued to conviction.
    5. Sponsorship and event routes: Prohibited categories reach audiences through sports and cultural sponsorship where the brand appears without any product claim. e.g. surrogate liquor branding through music, soda and sporting event sponsorship has continued despite the advertising prohibition.
    6. Enforcement capacity: State drug and food administrations are staffed for sampling and licensing work, not for evidentiary media investigations. e.g. food safety officer vacancies in several States leave routine sampling targets unmet, before any advertising inquiry is added.

    Conclusion

    The action against celebrity endorsers is a defensible extension of endorser liability into the enforcement stage, and it addresses a real asymmetry between who persuades and who pays the health cost. Its survival depends entirely on whether the inquiry under COTPA, 2003 and the Food Safety and Standards Act, 2006 meets the evidentiary standard the Delhi High Court fixed in 2024. A well grounded order would narrow the space for surrogate advertising across tobacco, health claims, education and finance. An unsupported one would leave the practice stronger than it found it.

    Advertising Regulation in India

    1. What it covers: Advertising regulation governs the content, placement and truthfulness of commercial communication, and reaches the advertiser, the agency, the publisher and the endorser.
    2. Mixed model: India uses statutory control for specific product categories alongside self regulation by the Advertising Standards Council of India (ASCI), a voluntary industry body whose code is not itself law.
    3. Statutory anchor since 2019: The Central Consumer Protection Authority (CCPA), constituted under the Consumer Protection Act, 2019, can order the discontinuation of a misleading advertisement and impose penalties on the advertiser and the endorser.
    4. Prohibited categories: Direct advertising of tobacco products is banned, and liquor advertising is restricted, which is precisely what creates the incentive for brand extension.
    5. Scale: India is among the world’s largest advertising markets by volume of impressions, with digital and influencer marketing now the fastest growing segment and the least documented.

    Laws and Rules Governing Advertising and Surrogate Promotion

    1. Cigarettes and Other Tobacco Products Act (COTPA), 2003: Prohibits direct and indirect advertisement, promotion and sponsorship of tobacco products and regulates sale to and around minors.
    2. Section 5: Bars advertisement of cigarettes and other tobacco products, including indirect advertisement, which is the provision surrogate advertising is tested against.
    3. Consumer Protection Act, 2019: Defines misleading advertisement, creates the CCPA, and imposes liability and penalties on manufacturers and endorsers.
    4. Endorser penalty: Provides monetary penalty on an endorser for a false or misleading advertisement, with a prohibition on further endorsements for a stated period on repetition.
    5. Food Safety and Standards Act, 2006: Regulates food product claims and advertising, and prohibits misleading claims about the nature, quality or health effect of a food.
    6. Cable Television Networks (Regulation) Act, 1995: Bars advertisement of prohibited products on cable television through the Advertisement Code framed under it.
    7. Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954: Prohibits advertisements claiming cure for listed diseases and conditions.
    8. Central Consumer Protection Authority (Prevention of Misleading Advertisements and Endorsements) Guidelines, 2022: Set conditions for a non misleading advertisement, regulate bait and surrogate advertisements, and fix due diligence duties for endorsers.
    9. Endorsement Know hows for digital advertising, 2023: Require celebrities, influencers and virtual influencers to disclose a material connection with the advertiser in a clear and prominent manner.

    Government Initiatives in Advertising and Consumer Protection

    1. National Tobacco Control Programme (NTCP): Implemented by the Ministry of Health and Family Welfare to enforce COTPA, run awareness campaigns and support cessation, targeted at tobacco users and youth.
    2. National Tobacco Quitline and mCessation: Provide telephone and mobile based cessation support to tobacco users seeking to quit.
    3. Jago Grahak Jago: Consumer awareness campaign of the Department of Consumer Affairs, aimed at informing consumers about misleading advertisements and grievance routes.
    4. National Consumer Helpline and the INGRAM portal: Give consumers a single point to lodge complaints against misleading advertisements and unfair trade practices.
    5. Eat Right India: Food Safety and Standards Authority of India (FSSAI) campaign to curb misleading food claims and promote safe and healthy food, aimed at consumers and food businesses.

    Key Facts about Tobacco Control and Advertising Regulation

    1. World No Tobacco Day is observed on 31 May each year.
    2. India has the world’s largest burden of oral cancer, which is the health basis for the strict treatment of tobacco surrogate advertising.
    3. India is a party to the World Health Organization Framework Convention on Tobacco Control (WHO FCTC), the first international public health treaty, which India ratified in 2004.
    4. Pictorial health warnings must cover 85 percent of the principal display area on both sides of a tobacco product package in India, among the largest such requirements globally.
    5. The Advertising Standards Council of India (ASCI) was set up in 1985 as a voluntary self regulatory body and its code has no statutory force of its own.

    Challenges in Advertising and Consumer Protection Regulation

    1. Self regulation without teeth: ASCI rulings bind only members and carry no penalty, so a non member advertiser faces no consequence. e.g. several offshore betting and crypto platforms advertising into India are outside ASCI’s membership entirely.
    2. Influencer economy outpaces disclosure rules: Paid endorsements are presented as personal opinion, and disclosure labels are omitted or hidden. e.g. financial influencers recommending securities without registration led the Securities and Exchange Board of India to restrict regulated entities from associating with unregistered advice givers.
    3. Dark patterns in digital interfaces: Design choices such as false urgency and forced action steer consumers without any express claim to test. e.g. the Department of Consumer Affairs notified guidelines in 2023 listing thirteen specified dark patterns on e commerce platforms.
    4. Regulatory capacity gap: The CCPA and State food and drug administrations have small investigation teams against a very large advertising volume. e.g. misleading claims in the coaching and edtech sector produced a separate CCPA advisory only after repeated complaints.
    5. Cross border advertising: Advertisements served from outside India for products banned within India are hard to reach through domestic statutes. e.g. offshore betting platforms advertise through surrogate news and sports content channels aimed at Indian audiences.
    6. Health claims without evidence: Immunity, weight loss and fortification claims sit between food law and drug law and are contested at the margin. e.g. claims on health supplements and nutraceuticals repeatedly draw FSSAI action for lacking substantiation.

    Back2Basics: Food Safety and Standards Authority of India (FSSAI)

    1. Governing Act: Established under the Food Safety and Standards Act, 2006.
    2. Year established: Constituted in 2008, with the Act’s substantive provisions brought into force from 2011.
    3. Parent ministry: Functions under the Ministry of Health and Family Welfare.
    4. Mandate: Lays down science based standards for articles of food and regulates their manufacture, storage, distribution, sale, import and advertising.
    5. Composition: Headed by a Chairperson of the rank of Secretary to the Government of India, with a Chief Executive Officer and members drawn from States, industry, consumer groups and food technology.
    6. Enforcement structure: Implemented on the ground by State Food Safety Commissioners, Designated Officers and Food Safety Officers, which is why a State FDA leads the present action.

    Way Forward

    1. Complete the statutory inquiry: Convert the summons into a documented proceeding under COTPA, 2003 and the Food Safety and Standards Act, 2006 that records evidence of the extension product’s dependent market identity.
    2. Define independent market identity: Notify an objective test combining sales volume, distribution reach and advertising spend of the extension product relative to the parent brand.
    3. Single window coordination: Create a joint mechanism between the CCPA, the health administration and State food and drug administrations so one authority carries a surrogate advertising case to conclusion.
    4. Raise the penalty to advertising spend: Link penalties to the advertising outlay of the campaign so the fine is not absorbed as a cost of business.
    5. Mandatory pre certification for prohibited categories: Require prior vetting of advertisements for brand names shared with tobacco and liquor products before release.
    6. Extend disclosure enforcement to digital: Audit influencer endorsements for the material connection disclosure and publish enforcement outcomes so the rule becomes visible.
    7. Consumer side remedy: Publicise the CCPA and National Consumer Helpline routes so complaints against misleading endorsements do not depend on regulator initiative alone.

    “[2014, GS2, 12.5 marks] The setting up of a Rail Tariff Authority to regulate fares will subject the cash strapped Indian Railways to demand subsidy for obligation to operate non-profitable routes and services. Taking into account the experience in the power sector, discuss if the proposed reform is expected to benefit the consumers, the Indian Railways or the private container operators.”

  • National Medical Commission proposes a single national licence to practise medicine

    Why in the News

    The National Medical Commission has notified draft regulations under which a doctor registered with any one State Medical Council would be able to practise anywhere in India without fresh registration, using a unique identification number in the National Medical Register. The right to practise is being nationalised while the power to discipline stays with the State where the alleged misconduct occurred.

    What do the draft Registration of Medical Practitioners and Licence to Practice Medicine (Amendment) Regulations, 2026 propose?

    1. The core change: A medical practitioner once registered with a State Medical Council would be eligible to practise across India without obtaining fresh registration or a licence in another State.
    2. The identifier: The practitioner would be allotted a Unique Identification (UID) number in the National Medical Register (NMR), which becomes the single reference for the right to practise.
    3. What it amends: The draft amends the 2023 regulations governing registration and licensing of doctors, and routes the process through a unified registration portal of the Commission's Ethics and Medical Registration Board.
    4. Stage and consultation: The draft was notified by the Commission on 11 August 2026, and objections and suggestions have been invited for 30 days from the date of notification.

    What is the National Medical Register (NMR)?

    1. Function: The National Medical Register is the central repository of registration details of all medical practitioners in India, maintained by the National Medical Commission alongside the State Medical Registers kept by each State Medical Council. Under the draft it would also hold disciplinary records and the active or inactive status of every licence.

    Who is the Ethics and Medical Registration Board?

    1. Role: The Ethics and Medical Registration Board is one of the four autonomous boards of the National Medical Commission, responsible for maintaining the National Medical Register and regulating professional conduct and ethics. Under the draft it would allot the unique identification number and operate the unified registration portal.

    How would the unique identification number work?

    1. Composition of the number: The unique identification number assigned in the register would incorporate the State or Union Territory code and the practitioner's State Medical Register number.
    2. Sequence of grant: The State Medical Council first grants registration, and the Ethics and Medical Registration Board then allots the unique identification number.
    3. Effect of allotment: Once the number is allotted, the doctor would not require fresh registration or a separate licence to practise in another State or Union Territory.
    4. Register synchronisation: The draft proposes automatic electronic synchronisation between the national and State registers, so a change made in one register is reflected in the other.

    What changes for State Medical Councils?

    1. Entry point unchanged: State Medical Councils would continue to scrutinise applications and to grant registration and licence for doctors to practise.
    2. Dual reflection of approval: The approval would be reflected in both the State Medical Register and the National Medical Register.
    3. Central oversight added: The Ethics and Medical Registration Board and the Commission would have powers to seek records and monitor State Medical Councils.
    4. The stated purpose of oversight: The monitoring power is intended to promote uniformity and transparency in regulation across States.

    How is disciplinary jurisdiction handled under the draft?

    1. Territorial principle retained: Disciplinary jurisdiction stays primarily with the State Council in whose territorial jurisdiction the alleged professional misconduct, unethical conduct or medical negligence occurred.
    2. Powers of that Council: It has the power to inquire into and decide the matter, and to record the outcome against the practitioner's credentials in the online register.
    3. Cross council cases: Where disciplinary action is recommended by a State Council other than the doctor's primary registering council, the action would be reflected in the National Medical Register.
    4. Automatic flow back: That action would then be automatically updated in the State register of the council of primary registration.
    5. What the register would carry: The National Medical Register would hold disciplinary proceedings including suspension, removal and restoration of registration, and details of disciplinary action taken.

    What happens to licence validity and renewal?

    1. Validity retained: The proposal retains the five year validity of a licence to practise.
    2. Renewal window: If a doctor does not apply for renewal within three months of expiry, the registration will be marked inactive.
    3. Consequence of inactive status: A practitioner whose registration is marked inactive is not entitled to practise medicine.
    4. Visibility of status: The National Medical Register would carry whether a doctor's licence is active or inactive, so the status is nationally visible.

    Does a national licence without a national disciplinary forum close the accountability gap?

    1. Portability of practice is immediate: A single number confers the right to practise in every State and Union Territory from the moment it is allotted.
    2. Portability of accountability is derived: Discipline still runs through whichever State Council has territorial jurisdiction over the place of the alleged misconduct, and reaches the rest of the country only through register synchronisation.
    3. The gap is procedural, not conceptual: If synchronisation lags or a State Council does not record an outcome, a suspended practitioner remains visible as active elsewhere.
    4. Uniformity of standards is not guaranteed: Different State Councils apply the professional conduct regulations with differing rigour, and a national licence carries the outcome of the least rigorous forum as readily as the most rigorous.
    5. The Commission's answer is oversight, not adjudication: The draft responds with powers to seek records and monitor State Councils rather than with a central disciplinary forum.

    Challenges to the proposed national licence framework

    1. Synchronisation dependence: The entire accountability design rests on electronic updates between the national and State registers working without delay. e.g. a suspension recorded by one State Council but not reflected in the National Medical Register would leave a barred doctor practising elsewhere.
    2. Uneven State Council capacity: State Medical Councils differ widely in staffing, digitisation and case disposal, and the weakest becomes the entry point for the whole country. e.g. State Councils with long pending complaint backlogs would still be the first scrutiny layer for national practice rights.
    3. Forum shopping in registration: Applicants may seek primary registration with the council perceived to have the lightest scrutiny, since the licence is then valid everywhere. e.g. the unique identification number carrying the State code makes the choice of registering State visible but does not restrict it.
    4. Renewal lapse risk: A three month renewal window creates a cliff on which an administrative omission ends the right to practise. e.g. a practitioner on long clinical assignment abroad missing the window and finding registration marked inactive.
    5. Data accuracy in the register: A national register carries forward whatever errors and duplicates the State registers already contain. e.g. duplicate entries across State registers have long complicated counts of registered allopathic practitioners in India.
    6. No stated appellate route in the draft: The draft records the State Council's power to inquire and decide without setting out a national appellate forum against an adverse finding. e.g. a doctor disciplined by a State Council other than the primary registering council faces consequences nationally through the register.
    7. Interface with the criminal and consumer forums: Professional discipline runs alongside criminal prosecution and consumer litigation, and the register reflects only the first. e.g. a practitioner facing a medical negligence complaint under the Consumer Protection Act, 2019 with no corresponding entry in the register.

    Conclusion

    The draft Registration of Medical Practitioners and Licence to Practice Medicine (Amendment) Regulations, 2026 stand notified by the National Medical Commission on 11 August 2026, with objections and suggestions invited for 30 days from the date of notification, which is the next milestone in the process. The proposal creates portable practice rights through a unique identification number while leaving discipline with the State Council of the place of misconduct. The accountability question turns on whether automatic synchronisation between the National Medical Register and the State registers actually works in practice. A national licence with a fragmented disciplinary record would widen mobility faster than it widens accountability.

    Medical Regulation in India

    1. The apex regulator: The National Medical Commission (NMC) regulates medical education and medical practice in India, having replaced the Medical Council of India in 2020.
    2. Four autonomous boards: The Under Graduate Medical Education Board, the Post Graduate Medical Education Board, the Medical Assessment and Rating Board, and the Ethics and Medical Registration Board.
    3. Two tier registration: Registration is granted by State Medical Councils and recorded in State Medical Registers, with the National Medical Register maintained centrally.
    4. Common entrance and exit: Admission to undergraduate and postgraduate medical courses runs through the National Eligibility cum Entrance Test, and the National Exit Test is provided for as a common final year and licentiate examination.
    5. Scale of the system: India has expanded medical college and undergraduate seat capacity substantially over the past decade, with the government citing a doctor to population ratio better than the World Health Organization norm of one per thousand when practitioners of all recognised systems are counted.
    6. Plural systems of medicine: Allopathic practice is regulated by the National Medical Commission. Ayurveda, Yoga, Unani and Siddha are regulated by the National Commission for Indian System of Medicine, and homoeopathy by the National Commission for Homoeopathy.

    Laws and Rules Governing Medical Practice in India

    1. National Medical Commission Act, 2019: Establishes the Commission and its four autonomous boards, provides for the National Medical Register, the National Eligibility cum Entrance Test and the National Exit Test, and repealed the Indian Medical Council Act, 1956.
    2. Statutory basis of the register: The Act requires a National Register of licensed practitioners to be maintained and made publicly available.
    3. Registration of Medical Practitioners and Licence to Practice Medicine Regulations, 2023: The regulations the present draft seeks to amend, governing registration and licensing procedure.
    4. National Medical Commission Registered Medical Practitioner (Professional Conduct) Regulations, 2023: Set out the ethical duties of doctors, including on prescribing by generic name, telemedicine and consent.
    5. Clinical Establishments (Registration and Regulation) Act, 2010: Provides for registration and minimum standards for clinical establishments in adopting States and Union Territories.
    6. Consumer Protection Act, 2019: Provides the forum for medical negligence claims as deficiency in service, separate from professional disciplinary proceedings.
    7. Drugs and Cosmetics Act, 1940: Regulates the manufacture, sale and prescription of drugs that registered practitioners are authorised to prescribe.
    8. Mental Healthcare Act, 2017: Governs the treatment and rights of persons with mental illness and the registration of mental health professionals and establishments.
    9. Transplantation of Human Organs and Tissues Act, 1994: Regulates removal, storage and transplantation of human organs, with obligations placed on registered practitioners.

    Government Initiatives in Medical Regulation and Health Human Resources

    1. National Medical Register portal: Launched by the Commission to create a verifiable public register of allopathic practitioners with unique identification numbers.
    2. Ayushman Bharat Digital Mission: Maintains the Healthcare Professionals Registry and the Health Facility Registry, linking verified practitioner identity to digital health records.
    3. Pradhan Mantri Swasthya Suraksha Yojana: Funds new All India Institutes of Medical Sciences and upgrades existing government medical colleges to expand tertiary care and teaching capacity.
    4. Centrally Sponsored Scheme for district hospital upgradation: Supports establishment of new medical colleges attached to existing district and referral hospitals in underserved districts.
    5. National Exit Test: Provided for under the National Medical Commission Act, 2019 as a single examination serving as the final year undergraduate examination, the licentiate examination and the postgraduate entrance test.
    6. Telemedicine Practice Guidelines, 2020: Permit registered practitioners to consult remotely within a defined professional and ethical framework.
    7. eSanjeevani: The national teleconsultation platform connecting patients to registered practitioners through health and wellness centres and directly from home.

    Key Facts about the National Medical Commission

    1. Year of operation: The Commission came into being in 2020 on the repeal of the Indian Medical Council Act, 1956 and the dissolution of the Medical Council of India.
    2. Composition: It is headed by a Chairperson and includes ex officio and part time members, with the presidents of the four autonomous boards as members.
    3. Medical Advisory Council: The Act creates a Medical Advisory Council as the primary platform through which States and Union Territories place their views before the Commission.
    4. Rating power: The Medical Assessment and Rating Board assesses and rates medical institutions and grants permission to establish new medical colleges.
    5. Fee regulation: The Commission frames guidelines for the determination of fees for a proportion of seats in private medical institutions and deemed universities.

    Challenges in Medical Regulation in India

    1. Maldistribution rather than absolute shortage: Doctors concentrate in metropolitan and urban districts while rural and tribal blocks remain unstaffed. e.g. persistent vacancies of specialists at Community Health Centres reported in successive Rural Health Statistics.
    2. Quackery and unqualified practice: Unregistered practitioners operate widely where regulated supply is thin, and a national register alone does not displace them. e.g. State Medical Councils issuing repeated public notices against unqualified practitioners in rural districts.
    3. Ethics enforcement capacity: Professional conduct proceedings are slow and outcomes are inconsistent across State Councils. e.g. complaints of professional misconduct pending for years before State Medical Councils.
    4. Cost of medical education: High private medical college fees shape both who enters the profession and where graduates practise. e.g. the Commission having to issue fee determination guidelines for a share of private and deemed university seats.
    5. Postgraduate seat bottleneck: Undergraduate seat expansion has outpaced postgraduate capacity, leaving a specialist training gap. e.g. the ratio of postgraduate to undergraduate seats remaining a standing constraint on specialist availability.
    6. Faculty shortage in new colleges: Rapid expansion of colleges has outrun the availability of qualified teaching faculty. e.g. assessment findings of faculty deficiencies at newly permitted medical colleges.
    7. Fragmented digital records: Practitioner data sits across State registers, the national register and separate health workforce databases with limited reconciliation. e.g. duplicate and outdated entries complicating any count of practising allopathic doctors.

    Back2Basics: National Medical Commission (NMC)

    1. Governing Act: Established under the National Medical Commission Act, 2019.
    2. Year established: Constituted in 2020, replacing the Medical Council of India which functioned under the Indian Medical Council Act, 1956.
    3. Parent ministry: Functions under the Union Ministry of Health and Family Welfare.
    4. Jurisdiction: Regulates medical education, medical institutions, medical research and medical professionals in the allopathic system across India.
    5. Composition: A Chairperson, ex officio members including the presidents of the four autonomous boards, part time members, and members representing States and Union Territories on a rotational basis.
    6. Autonomous boards: Under Graduate Medical Education Board, Post Graduate Medical Education Board, Medical Assessment and Rating Board, and Ethics and Medical Registration Board.
    7. Core mandate: To improve access to quality and affordable medical education, ensure availability of adequate and high quality medical professionals, and maintain a national register of licensed practitioners.
    8. Key instruments: The National Eligibility cum Entrance Test, the National Exit Test, the National Medical Register and the professional conduct regulations.

    Way Forward

    1. Guarantee synchronisation by design: Build the national and State registers on a single source of truth rather than on periodic updates, so that a suspension takes effect nationally the moment it is recorded.
    2. Set uniform disciplinary standards: Issue binding procedure and timeline norms for State Council inquiries, so that a national licence does not carry the outcome of the weakest forum.
    3. Create a national appellate tier: Provide an appeal from a State Council's disciplinary decision to the Ethics and Medical Registration Board, since the consequence of that decision is now national.
    4. Clean the register before nationalising it: Complete deduplication and verification of State registers before unique identification numbers become the basis of practice rights everywhere.
    5. Make the register publicly searchable: Allow patients and employers to verify a practitioner's licence status and disciplinary record by unique identification number, which is the only way a register changes behaviour.
    6. Provide a renewal grace mechanism: Allow reactivation on application with reasons where the three month window has lapsed for demonstrable cause, so that an administrative lapse does not end a career.
    7. Use the register for workforce planning: Link active licence data to district level workforce mapping so that maldistribution can be measured and addressed rather than estimated.

    Matching Previous Year Question

    “No direct PYQ traced in the provided files. Closest microtheme: Sectoral Regulatory Bodies.”

  • Editorial on the Air India AI 2379 reclassification argues crew testing over emphasises alcohol breathalysers relative to psychoactive substances under the Civil Aviation Requirements

    Why in the News

    The 4 August 2026 flight from Phuket to Delhi, carrying 137 passengers and eight crew, has been reclassified from an event of turbulence to a serious incident after technical faults and a significant altitude deviation injured more than 20 people on board. The post flight screening of the pilot in command for psychoactive substances has exposed a crew fitness regime built around alcohol breathalysers rather than drug testing.

    What are the Civil Aviation Requirements (CAR)?

    1. About: The Civil Aviation Requirements are the binding regulatory instructions issued by the Directorate General of Civil Aviation (DGCA) under the aircraft rules, organised into numbered Sections and Series that operators must comply with to hold and retain approvals.
    2. The relevant provision: Crew testing for psychoactive substances falls under CAR Section 5, Air Safety, Series F, Part V, which also applies to Air Traffic Controllers.
    3. Its testing design: The requirement leans towards random and post flight or post shift testing with graded disciplinary action for a confirmed positive result.

    What is a serious incident in civil aviation?

    1. About: A serious incident is an occurrence involving circumstances indicating that an accident nearly occurred, a category distinct from an accident by the absence of the resulting damage or injury threshold.
    2. Why the label matters: Reclassification from turbulence to a serious incident makes a formal independent investigation mandatory rather than leaving the occurrence to airline level reporting.

    What is the Aircraft Accident Investigation Bureau?

    1. About: The Aircraft Accident Investigation Bureau (AAIB) is the body under the Ministry of Civil Aviation that investigates aircraft accidents and serious incidents, kept institutionally separate from the DGCA so the regulator does not investigate outcomes of its own oversight.
    2. International participation: Investigations draw in the safety authority of the State of design and manufacture, which is why France’s Bureau d’Enquetes et d’Analyses (BEA) and technical representatives of the manufacturer have joined this probe.

    What are psychoactive substances in the aviation context?

    1. About: Psychoactive substances are drugs that act on the central nervous system and alter perception, mood or cognition, covering narcotics, sedatives, hypnotics, cannabis, stimulants and certain over the counter medications.
    2. Why they matter on the flight deck: They impair judgement, reaction time, coordination and decision making, which are the four skills a flight crew relies on during an abnormal event.

    What actually happened on the flight?

    1. Two parallel tracks: The occurrence now has a technical track and a crew fitness track, and the second has drawn the greater attention.
    2. The technical anomalies: The Airbus A320N briefly carried fault warnings across the hydraulic systems, elevator flight control faults, autopilot disconnection, emergency exit door indications and an engine anti ice warning.
    3. The consequence: Inflight technical issues and a significant deviation in aircraft altitude caused injuries to more than 20 passengers and crew.
    4. The manufacturer’s data: Airbus’s initial data is said to support the evidence of technical errors.
    5. The airline’s response: The operator has begun immediate and mandatory screening of its flight deck crew for any substances or unprescribed medications.

    Why does the current crew screening regime under detect impairment?

    1. The testing asymmetry: Pre flight and post flight breathalyser checks for alcohol are routine and near universal, while testing for psychoactive substances is comparatively sparse.
    2. Detection after the event, not before: The pilot in command’s result surfaced through post flight screening following an incident, which means the system caught the risk only after passengers were injured.
    3. Random testing as the primary tool: A regime built on random and post shift sampling cannot guarantee that an impaired crew member is stopped before a specific flight departs.
    4. Voluntary action filling a regulatory gap: Mandatory screening began because a single airline was prodded into it, not because the requirement applies uniformly across operators.
    5. Rising exposure: Expanding operations, crew citing stress related issues, and wider availability of substances for medicinal or recreational use together enlarge the risk the regime is not sized for.

    What does the regulator’s own evidence base already establish?

    1. The medical circular: DGCA Medical Circular No. 02 of 2021 on over the counter drugs and self medication flags impairment of pilot cognitive and psychomotor skills.
    2. The Indian precedents it draws on: The circular draws on the Mangaluru (2010) and Kozhikode (2020) fatal air accidents. The 2010 crash of an Air India Express flight at Mangaluru killed 158 people after a runway overrun on a tabletop runway, and the 2020 accident at Kozhikode killed 21 in a similar runway excursion.
    3. International documentation: Documented cases from Western jurisdictions show that even small levels of impairment affect crew judgement, reaction time, coordination and decision making.
    4. The implication: The evidence linking impairment to fatal outcomes already exists in the regulator’s own material, so the gap is enforcement design rather than knowledge.

    Challenges to crew fitness regulation in India

    1. Self reporting of medication and illness: Disclosure of prescribed and over the counter drug use depends on the crew member volunteering it, with a licence at stake. e.g. DGCA Medical Circular No. 02 of 2021 exists precisely because self medication goes undeclared.
    2. Punitive rather than rehabilitative framing: Graded disciplinary action deters disclosure of a substance or mental health problem instead of surfacing it. e.g. pilot bodies have repeatedly objected that a positive breathalyser result triggers suspension without a treatment pathway.
    3. Fatigue rules lagging operations: Flight duty time limitations are revised slowly while network expansion increases night operations. e.g. revised flight duty time limitation norms for night duty and weekly rest were phased in only after sustained pilot representations.
    4. Testing infrastructure at smaller stations: Drug testing requires sample collection, chain of custody and accredited laboratories that are absent outside metro airports. e.g. a post flight test at a small regional airport under the regional connectivity network has no on site collection facility.
    5. Thin regulatory staffing against a growing fleet: Oversight capacity has not scaled with aircraft and operator numbers. e.g. the International Civil Aviation Organization’s safety oversight audits have repeatedly flagged vacancies in the technical cadre of the Indian regulator.
    6. Air Traffic Controllers inside the same requirement, outside the same attention: The requirement covers controllers, and the screening debate stays confined to flight deck crew. e.g. controller fatigue and staffing shortfalls at busy terminal control areas rarely feature in post incident action.

    Conclusion

    The reclassification converts an event described as turbulence into a serious incident with a formal investigation into both airframe faults and crew fitness. The crew screening system detected a psychoactive substance result only after an incident had already injured more than 20 people, because the regime is built around alcohol breathalysers and random sampling. The next step is the Aircraft Accident Investigation Bureau’s findings with the French authority and the manufacturer, and the immediate question for the regulator is whether mandatory psychoactive substance screening becomes a uniform requirement across operators rather than one airline’s response. Safety here depended on the aircraft recovering, and that is an outcome, not a control.

    Civil Aviation Safety Regulation in India

    1. About: Civil aviation safety in India is regulated by the Directorate General of Civil Aviation under the Ministry of Civil Aviation, which certifies aircraft, licenses crew, approves operators and issues the Civil Aviation Requirements.
    2. Investigation function: Accidents and serious incidents are investigated by the Aircraft Accident Investigation Bureau, kept separate from the regulator, in line with the International Civil Aviation Organization’s Annex 13 principle that investigation is for prevention and not for apportioning blame.
    3. Economic regulation: The Airports Economic Regulatory Authority sets tariffs for major airports, and the Airports Authority of India provides air navigation services and manages airports.
    4. Scale: India is among the largest domestic aviation markets in the world, with fleet and passenger volumes growing faster than regulatory staffing.
    5. International anchor: India is a founding member of the International Civil Aviation Organization, and Indian standards derive from the Chicago Convention, 1944 and its Annexes.

    Laws and Rules Governing Civil Aviation Safety

    1. Bharatiya Vayuyan Adhiniyam, 2024: The principal aviation statute, which replaced the Aircraft Act, 1934 and governs the manufacture, possession, use, operation and sale of aircraft.
    2. Retains the power to make rules for licensing of personnel, airworthiness and investigation of accidents, and provides for statutory recognition of the regulator and the investigation bureau.
    3. Aircraft Act, 1934: The predecessor statute under which the existing rules and requirements were framed and which continues to supply their legal lineage.
    4. Aircraft Rules, 1937: Contain the operative rules on airworthiness, crew licensing, and prohibition on flying under the influence of alcohol or psychoactive substances.
    5. Rule 24 prohibits any person from acting as a crew member while under the influence of intoxicating liquor or drugs.
    6. Aircraft (Investigation of Accidents and Incidents) Rules, 2017: Provide the legal basis for the Aircraft Accident Investigation Bureau and define accident, incident and serious incident.
    7. Civil Aviation Requirements: Subordinate regulatory instructions of the DGCA, with Section 5, Series F, Part V governing psychoactive substance testing of crew and air traffic controllers.
    8. Airports Economic Regulatory Authority of India Act, 2008: Establishes the economic regulator for major airports.
    9. Anti Hijacking Act, 2016: Provides for the offence of hijacking and prescribes the death penalty where the offence results in death of a hostage or security personnel.
    10. Carriage by Air Act, 1972: Gives effect in India to the Warsaw and Montreal Conventions on carrier liability to passengers.

    Back2Basics: Directorate General of Civil Aviation (DGCA)

    1. Type: Attached office of the Ministry of Civil Aviation, functioning as India’s civil aviation regulator.
    2. Governing law: Operates under the Bharatiya Vayuyan Adhiniyam, 2024, which replaced the Aircraft Act, 1934, and the Aircraft Rules, 1937.
    3. Mandate: Regulation of air transport services, enforcement of civil air regulations, air safety and airworthiness standards.
    4. Functions: Registration of civil aircraft, certification of airworthiness, licensing of pilots, engineers and air traffic controllers, and grant of air operator certificates.
    5. Instruments: Issues Civil Aviation Requirements, Aeronautical Information Circulars and Medical Circulars.
    6. International role: Coordinates regulatory functions with the International Civil Aviation Organization, which was founded in 1944 under the Chicago Convention and is headquartered in Montreal.
    7. Related bodies: The Bureau of Civil Aviation Security handles aviation security, and the Aircraft Accident Investigation Bureau handles accident and serious incident investigation.

    Government Initiatives in Civil Aviation

    1. National Civil Aviation Policy, 2016: The first integrated civil aviation policy, covering regional connectivity, safety, maintenance and repair, and air cargo.
    2. UDAN (Ude Desh ka Aam Naagrik) Regional Connectivity Scheme: Connects unserved and underserved airports through capped fares and viability gap funding.
    3. Krishi UDAN: Supports air transport of perishable agricultural produce from hill, tribal and North Eastern regions.
    4. Digi Yatra: Facial recognition based contactless passenger processing at airports.
    5. eGCA: Digitisation of the regulator’s licensing, examination and approval processes to cut manual discretion.
    6. NABH Nirman: Initiative to expand airport capacity to handle a billion trips.
    7. Aviation Safety Programme and State Safety Programme: Framework of safety management systems, mandatory occurrence reporting and safety performance indicators for operators.
    8. Maintenance, Repair and Overhaul policy support: Tax and customs measures to develop domestic aircraft maintenance capacity.

    Key Facts about Civil Aviation Safety

    1. The Chicago Convention, 1944 created the International Civil Aviation Organization, headquartered in Montreal, and India is a founding member.
    2. Annex 13 of the Chicago Convention governs aircraft accident and incident investigation, and defines a serious incident.
    3. The Aircraft Accident Investigation Bureau was constituted in 2012 and functions under the Aircraft (Investigation of Accidents and Incidents) Rules, 2017.
    4. International Civil Aviation Day is observed on 7 December.
    5. The Mangaluru accident of 2010 killed 158 people and the Kozhikode accident of 2020 killed 21, both at tabletop runways.
    6. The Bharatiya Vayuyan Adhiniyam, 2024 replaced the Aircraft Act, 1934 as India’s principal aviation statute.
    7. CAR Section 5, Series F, Part V is the specific requirement governing psychoactive substance testing of crew and air traffic controllers.

    Challenges in India’s Civil Aviation Sector

    1. Regulator capacity against fleet growth: Technical posts remain vacant while aircraft numbers, operators and flights expand. e.g. International Civil Aviation Organization safety oversight audits have flagged shortfalls in trained flight operations inspectors.
    2. Airport and airspace congestion: Slot and runway capacity at metro airports lags demand, which compresses turnaround times and crew rest. e.g. Delhi and Mumbai airports operating near saturation during peak banks.
    3. Airline financial fragility: Thin margins push cost cutting into maintenance, training and rostering. e.g. the collapse of Jet Airways in 2019 and of Go First in 2023 left aircraft grounded and crew displaced.
    4. Skilled manpower shortage: Pilots, aircraft maintenance engineers and air traffic controllers are trained in numbers below the sector’s expansion rate. e.g. Indian carriers holding large order books have had to lease aircraft with foreign crew.
    5. Maintenance dependence on foreign facilities: A limited domestic maintenance base sends heavy checks abroad, raising cost and turnaround time. e.g. a large share of Indian airline heavy maintenance has historically been done in Sri Lanka, Singapore and West Asia.
    6. Bird strike and wildlife hazard at airports: Waste dumps and abattoirs near airport perimeters draw birds into approach paths. e.g. recurring bird strike reports at airports adjoining municipal landfill sites.
    7. Weather and terrain risk at critical airfields: Tabletop runways and monsoon operations narrow the safety margin. e.g. the Kozhikode runway excursion in heavy rain in 2020.

    Way Forward

    1. Make psychoactive substance screening mandatory and uniform: Extend routine pre flight and post flight screening for substances beyond alcohol across every operator rather than leaving it to voluntary action.
    2. Build a non punitive disclosure pathway: Create a confidential reporting and rehabilitation route for crew with a substance or mental health problem, with return to duty after medical clearance.
    3. Expand testing infrastructure: Provide accredited sample collection and chain of custody facilities at regional airports, not only at metro stations.
    4. Strengthen fatigue risk management: Enforce revised flight duty time limitations with audited rostering data instead of self declared compliance.
    5. Staff the regulator: Fill technical inspector vacancies and give the regulator recruitment autonomy so oversight scales with fleet growth.
    6. Extend the same rigour to Air Traffic Controllers: Apply the testing and fatigue standards uniformly to controllers, who are already covered by the same requirement.
    7. Publish investigation findings promptly: Release Aircraft Accident Investigation Bureau reports with safety recommendations and track their implementation publicly.

    PYQ:

    “`

    [2015, GS2, 12 marks] For achieving the desired objectives, it is necessary to ensure that the regulatory institutions remain independent and autonomous. Discuss in the light of the experiences in recent past.

    “`

  • IRDAI Reforms to Revamp the Insurance Sector

    Why in News?

    The Insurance Regulatory and Development Authority of India (IRDAI) approved a series of reforms to modernise the insurance sector and implement the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Act, 2025.

    Key Highlights

    • Reforms aim to:
      • Improve ease of doing business.
      • Enhance insurance penetration.
      • Strengthen governance and policyholder protection.
      • Provide greater operational and financial flexibility to insurers.
    • Liberalised norms for Investments. Capital infusion. Corporate restructuring. Transfer of shares and amalgamation of insurers.
    • Policyholders’ Education and Protection Fund (PEPF) operationalised under Section 16A of the IRDA Act, 1999 to Promote insurance awareness. Improve grievance redressal. Trace unclaimed insurance amounts. Enhance policyholder services.
    • Insurance intermediaries reforms:
      • Mandatory tagging of the authorised salesperson with every insurance proposal and policy.
      • Perpetual registration for intermediaries through an annual fee system, replacing periodic renewals.

    About IRDAI

    • Statutory regulator established under the IRDA Act, 1999.
    • Regulates, promotes, and ensures orderly growth of the insurance sector.
    • Headquarters: Hyderabad.

    Prelims Facts

    • IRDA Act, 1999 established IRDAI.
    • PEPF aims to strengthen insurance literacy and policyholder protection.
    • The reforms implement the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Act, 2025.

    [2019] In India, which of the following bodies/mechanisms review the functioning of independent regulators like PFRDA, IBBI, AERA, and PNGRB?
    1.Ad Hoc Committees appointed by the Parliament.
    2.Parliamentary Standing Committees.
    3.NITI Aayog.
    4.Financial Sector Legislative Reforms Commission (FSLRC).
    5.Finance Commission.
    Select the correct answer using the code given below:

    [A] 1 and 2 only

    [B] 1, 3, and 4

    [C] 2, 4, and 5

    [D] 2 only

  • On guard: on India and the Qdenga dengue vaccine

    Why in the News?

    India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved Qdenga, the country’s first dengue vaccine, after its licensing in over 40 countries and World Health Organisation (WHO) prequalification, arriving amid some of India’s worst dengue outbreaks.

    Why was developing any dengue vaccine so difficult in the first place?

    1. Four serotypes must be defeated at once: The four antigenically distinct dengue serotypes (DENV-1, DENV-2, DENV-3, DENV-4) require a vaccine to generate strong immunity against all four simultaneously.
    2. The antibody-dependent enhancement (ADE) risk: A second infection with a different serotype can cause more severe disease through antibody-dependent enhancement (ADE), the mechanism that undermined the first licensed dengue vaccine, Dengvaxia, and led to the 2017 Philippines controversy.
    3. Qdenga’s design choice: Developed by Japan-based Takeda, Qdenga differs from Dengvaxia and does not require prior screening for previous dengue infection before vaccination.

    What specific gaps in Qdenga’s protection could undermine its rollout this monsoon?

    1. Uneven serotype coverage: Protection is highest against DENV-2, followed by DENV-1, while uncertainty remains regarding DENV-3 and DENV-4 in seronegative individuals.
    2. A rising mismatch: Although DENV-2 currently predominates in India, DENV-3 is increasing. If DENV-3 becomes dominant during the 2026 monsoon, the vaccine’s real-world effectiveness could decline, especially among those with no prior dengue exposure.
    3. A dangerous timing gap: Qdenga requires two doses administered three months apart. The first dose provides uneven protection, leaving seronegative individuals vulnerable if exposed to DENV-3 before completing the vaccination schedule.
    4. A specific trial finding on vulnerable children: The Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial raised concerns about negative efficacy against hospitalisation related to DENV-3 among seronegative children who do not complete both doses.

    Why is the vaccine’s price, not just its science, presented as the real barrier to protection?

    1. The mobile workforce problem: Ensuring that migrant workers receive the second dose on schedule will be difficult, increasing the risk highlighted in the TIDES trial.
    2. Tiered pricing risks excluding vulnerable groups: Under Takeda’s global tiered pricing strategy, Qdenga may remain unaffordable for residents of dense urban slums with poor drainage, who face the highest exposure to Aedes mosquitoes.
    3. The Aedes mosquito’s changing range compounds the problem: Aedes mosquitoes are spreading into semi-urban and rural areas, making vector control more difficult and expanding the population requiring affordable vaccination.

    Conclusion

    The approval of Qdenga is a significant milestone in India’s fight against dengue, but its public health impact depends on addressing serotype-specific protection gaps, ensuring completion of the two-dose schedule, and making the vaccine affordable for high-risk populations. The editorial argues that price negotiations are essential for the vaccine to achieve meaningful public health outcomes.

    Back2Basics

    About Dengue:

    1. Dengue (break-bone fever) is a viral infection that is spread from mosquitoes to people. It is more common in tropical and subtropical than in temperate climates.
    2. Transmission: The dengue virus is transmitted to humans through the bites of infected female mosquitoes, primarily the Aedes aegypti mosquito. Other species within the Aedes genus can also act as vectors, but their contribution is normally secondary to Aedes aegypti.
    3. Human-to-mosquito transmission: Mosquitoes can become infected by people who are viremic with DENV. This can be someone who has a symptomatic dengue infection, someone who is yet to have a symptomatic infection (those who are pre-symptomatic), and also someone who shows no signs of illness (those who are asymptomatic).

    Dengue Serotype

    1. Four Types: The virus exists as four closely related strains: DENV-1, DENV-2, DENV-3, and DENV-4.
    2. Immunity: Catching one serotype gives you lifelong immunity to that specific type, but only short protection against the other three.
    3. Severe Risk: Getting infected a second time by a different serotype can raise your chance of getting severe dengue.

    Important Keywords:

    1. Antibody-dependent enhancement (ADE): A phenomenon in which antibodies generated from a previous infection with one dengue serotype enhance, rather than prevent, severe disease during infection with a different serotype, making dengue vaccine development particularly challenging.
    2. WHO prequalification: A World Health Organization (WHO) assessment that certifies a vaccine meets international standards of quality, safety, and efficacy, enabling procurement by governments and international agencies.

    PYQ Relevance

    [UPSC 2022] What is the basic principle behind vaccine development? How do vaccines work? What approaches were adopted by the Indian vaccine manufacturers to produce COVID-19 vaccines?

    Linkage: The PYQ examines the science behind vaccine development and immunization, a core GS-3 Science & Technology theme. The article applies these principles to dengue, highlighting challenges of multi-serotype vaccines, ADE, efficacy, and rollout.

  • CCPA Penalises SpiceJet for Use of Dark Patterns

    Why in News?

    The Central Consumer Protection Authority (CCPA) imposed a ₹1 lakh penalty on SpiceJet for using dark patterns on its flight booking platform, violating consumer protection laws.

    Key Highlights

    • Violation: Use of dark patterns that manipulated consumer choices.
    • Dark Patterns Identified:
      • Forced Action: Automatic enrolment into SpiceClub via pre-ticked checkbox.
      • Interface Interference: Default selection of the company’s preferred options.
      • Trick Question: Confusing and negatively worded consent language.
    • Legal Violations:
      • Consumer Protection Act, 2019.
      • Rule 4(9) of the Consumer Protection (E-Commerce) Rules, 2020.
      • Guidelines for Prevention and Regulation of Dark Patterns, 2023.
    • CCPA’s Observation: Consumer consent must be explicit, informed, and voluntary; consent obtained through pre-ticked checkboxes or deceptive interfaces is invalid.

    Prelims Facts

    • Central Consumer Protection Authority (CCPA):
      • Established under the Consumer Protection Act, 2019.
      • Functions under the Department of Consumer Affairs.
      • Protects consumer rights and regulates unfair trade practices, misleading advertisements, and unfair contracts.
    • Dark Patterns: User interface designs that deceive or manipulate consumers into making unintended choices.

  • NESAC Strengthens Space-Based Governance in Northeast

    Why in News?

    The Union Minister reviewed the initiatives of the North Eastern Space Applications Centre (NESAC), highlighting its role in border management, disaster resilience, and socio-economic development in the Northeast

    Key Highlights

    • NESAC: North Eastern Space Applications Centre, located at Umiam, Meghalaya.
    • Implementing ~130 space application projects, including 78 ongoing and 50 recently completed.
    • Supporting geospatial mapping of the India-Myanmar border and inter-state boundaries.
    • Key sectors covered: Agriculture, Disaster Management, Water Resources, Forestry, Urban & Regional Planning, Geoinformatics, Satellite Communication, UAV (Unmanned Aerial Vehicle) applications
    • Promoting bamboo resource mapping in collaboration with NECBDC (North East Cane and Bamboo Development Council).
    • Strengthening flood early warning systems and the GeoTourism ‘ManzilNE’ dashboard.
    • Encouraged partnerships with State Governments, academia, startups, and industry to expand space-based applications.

    About NESAC

    • Established in 2000 as a joint initiative of ISRO (Indian Space Research Organisation) and the North Eastern Council (NEC).
    • Provides space technology, remote sensing, GIS (Geographic Information System), satellite communication, and disaster management support for the eight Northeastern States.

    [2024] The North Eastern Council (NEC) was established by the North Eastern Council Act, 1971. Subsequent to the amendment of NEC Act in 2002, the Council comprises which of the following members?
    1. Governor of the Constituent State
    2. Chief Minister of the Constituent State
    3. Three Members to be nominated by the President of India
    4. The Home Minister of India
    Select the correct answer using the code given below:

    [A] 1, 2 and 3 only

    [B] 3 and 4 only

    [C] 2 and 4 only

    [D] 1, 2, 3 and 4

  • The product diversification of financial institutions and insurance companies, resulting in overlapping of products and services strengthens the case for the merger of the two regulatory agencies, namely SEBI and IRDA. Justify.

  • The setting up of a Rail Tariff Authority to regulate fares will subject the cash strapped Indian Railways to demand subsidy for obligation to operate non-profitable routes and services. Taking into account the experience in the power sector, discuss if the proposed reform is expected to benefit the consumers, the Indian Railways or the private container operators.

  • For achieving the desired objectives, it is necessary to ensure that the regulatory institutions remain independent and autonomous. Discuss in the light of theexperiences in recent past.